Episode Details

Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Orezeyful

Pharmaceutical Executive Daily: FDA Approves Orezeyful

Published 3 months, 1 week ago
Description
In today's Pharmaceutical Executive Daily, an antitrust attorney weighs the legal risks of a hypothetical AstraZeneca-Bristol Myers Squibb merger, Eli Lilly beats Wall Street estimates on soaring Mounjaro and Zepbound sales and raises its full-year guidance, and the FDA approves Moderna's first mRNA-based flu vaccine for adults 50 and older.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us